Marty Makary, the 27th Commissioner of the U.S. FDA, shared a post on X:
“We’re deeply committed to reforming our IND/Phase 1 process.
We must retain our position as the world leader in biotech.”
Other articles featuring Marty Makary on OncoDaily.
Marty Makary